Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells.
Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells.
复制标题
DOI:
10.1016/j.omtn.2021.12.029
复制
发表时间:
2022-03-08
期刊:
影响因子:
--
通讯作者:
Kortylewski M
中科院分区:
文献类型:
--
作者:
Adamus T;Hung CY;Yu C;Kang E;Hammad M;Flores L;Nechaev S;Zhang Q;Gonzaga JM;Muthaiyah K;Swiderski P;Aboody KS;Kortylewski M
Tropism of neural stem cells (NSCs) to hypoxic tumor areas provides an opportunity for the drug delivery. Here, we demonstrate that NSCs effectively transport antisense oligonucleotides (ASOs) targeting oncogenic and tolerogenic signal transducer and activator of transcription 3 (STAT3) protein into glioma microenvironment. To enable spontaneous, scavenger receptor-mediated endocytosis by NSCs, we used previously described CpG-STAT3ASO conjugates. Following uptake and endosomal escape, CpG-STAT3ASO colocalized with CD63+ vesicles and later with CD63+CD81+ exosomes. Over 3 days, NSCs secreted exosomes loaded up to 80% with CpG-STAT3ASO. Compared to native NSC exosomes, the CpG-STAT3ASO-loaded exosomes potently stimulated immune activity of human dendritic cells or mouse macrophages, inducing nuclear factor κB (NF-κB) signaling and interleukin-12 (IL-12) production. Using orthotopic GL261 tumors, we confirmed that NSC-mediated delivery improved oligonucleotide transfer from a distant injection site into the glioma microenvironment versus naked oligonucleotides. Correspondingly, the NSC-delivered CpG-STAT3ASO enhanced activation of glioma-associated microglia. Finally, we demonstrated that NSC-mediated CpG-STAT3ASO delivery resulted in enhanced antitumor effects against GL261 glioma in mice. Peritumoral injections of 5 × 105 NSCs loaded ex vivo with CpG-STAT3ASO inhibited subcutaneous tumor growth more effectively than the equivalent amount of oligonucleotide alone. Based on these results, we anticipate that NSCs and NSC-derived exosomes will provide a clinically relevant strategy to improve delivery and safety of oligonucleotide therapeutics for glioma treatment. Here, we demonstrate that tropism of neural stem cells to hypoxic tumor areas allows for oligonucleotide delivery. NSCs secreting exosome-encapsulated CpG-STAT3ASOs induced antitumor effects against glioma in mice. We believe that NSC-mediated transfer of oligonucleotide therapeutics is an opportunity for safer and more effective treatment of brain tumors.
登录
查看更多内容
影响因子:
16
作者:
Mateescu B;Kowal EJ;van Balkom BW;Bartel S;Bhattacharyya SN;Buzás EI;Buck AH;de Candia P;Chow FW;Das S;Driedonks TA;Fernández-Messina L;Haderk F;Hill AF;Jones JC;Van Keuren-Jensen KR;Lai CP;Lässer C;Liegro ID;Lunavat TR;Lorenowicz MJ;Maas SL;Mäger I;Mittelbrunn M;Momma S;Mukherjee K;Nawaz M;Pegtel DM;Pfaffl MW;Schiffelers RM;Tahara H;Théry C;Tosar JP;Wauben MH;Witwer KW;Nolte-'t Hoen EN
通讯作者:
Nolte-'t Hoen EN
影响因子:
16
作者:
Lötvall J;Hill AF;Hochberg F;Buzás EI;Di Vizio D;Gardiner C;Gho YS;Kurochkin IV;Mathivanan S;Quesenberry P;Sahoo S;Tahara H;Wauben MH;Witwer KW;Théry C
通讯作者:
Théry C
影响因子:
46.9
作者:
Alvarez-Erviti, Lydia;Seow, Yiqi;Wood, Matthew J. A.
通讯作者:
Wood, Matthew J. A.
DOI:
10.1126/science.aau6977
发表时间:
2020-02-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Kalluri R;LeBleu VS
通讯作者:
LeBleu VS
影响因子:
10.8
作者:
Kooijmans, Sander A. A.;Stremersch, Stephan;Vader, Pieter
通讯作者:
Vader, Pieter